SABIC Reports Successful Step Towards Creating Circular Polymers Based On Advanced Recycling of Used Medical Plastic

Collaboration with dialysis department at Jessa Hospital, Belgium, in proof-of-concept pilot project. Project has shown that non-contaminated used medical plastic can be repurposed for advanced recycling and subsequent production of medical grade polymers as part of SABIC’s TRUCIRCLE™ portfolio. The pilot project could be translated into other regions

SABIC

SABIC, a global leader in the chemical industry, has successfully demonstrated the feasibility of recycling used medical plastic back into the medical materials stream. The project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium. Serving as a pilot proof-of-concept, used medical plastic generated at Jessa’s hospital was converted to pyrolysis oil in an advanced recycling process, delivering circular feedstock for SABIC’s production of TRUCIRCLE™ polymers in medical grade quality with same performance, purity and physiological safety as virgin-based medical grade polymers. This is indispensable for medical approvals by regulators.

Lada Kurelec, General Manager, Polymers Technology & Innovation at SABIC, states:

“Working with Jessa Hospital has been an immensely rewarding experience, where we learned how individual belief in circularity can mobilize industry to work together. I value how this collaboration enabled creation of an ecosystem to collect and recycle non-contaminated medical waste in a very short time. Thanks to this collaboration, we are creating a certified circular TRUCIRCLE™ polymer portfolio able to serve the healthcare market. We are inviting other players in the value chain and in other regions to join us and Jessa in this ground-breaking initiative to accelerate the circularity of plastics in the medical industry.”

Advanced recycling technology and the vast experience gained through its TRUCIRCLE™ solutions put SABIC in a strong position to provide a circular solution designed to help Jessa Hospital reduce the environmental footprint of its medical products by avoiding their incineration after use. Approximately 85% of the used medical plastic generated at the hospital is not contaminated and therefore requires no specialized treatment. This allows it to be repurposed as feedstock for advanced recycling and subsequent production of high-quality medical grade polymers, saving virgin raw material and contributing to a more circular medical economy.

Karl Zwinnen, Project Engineer at Jessa adds:

“We are very pleased with the advanced and circular recycling approach enabled by SABIC to improve our medical waste management. The setup of an efficient collection system for used medical plastic has met with strong support among our medical and healthcare staff. Besides contributing to enhanced sustainability and circularity, the solution also has an enormous potential for reducing our disposal costs. We look forward to implementing it across all Jessa locations.”

As a result of this successful pilot project, SABIC is currently in the process of actively engaging partners to scale up operations and create a fully closed-loop recycling model for used medical plastic in larger volumes. Furthermore, there is the potential to initiate other similar pilot projects in other countries including the United States.

Circular Materials

SABIC’s certified circular materials are produced using mass balance accounting according to the International Sustainability & Carbon Certification (ISCC) PLUS program, which defines a set of transparent rules for tracking the material flow across complex supply chains from the feedstock to final applications. The resulting certified circular polymers form part of the company’s TRUCIRCLE™ portfolio and services.

TRUCIRCLE™ Portfolio

SABIC’s TRUCIRCLE™ portfolio and services include certified circular polymers as well as design for recyclability, mechanically recycled products, certified renewable polymers from bio-based feedstock, and closed loop initiatives to recycle plastic back into high-quality applications and help prevent valuable used plastics from becoming waste.

SourceSABIC

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.